Pharmacists in Fort George G Meade, Maryland


11 Pharmacists found in Fort George G Meade
male pharmacist

Aldric Jameson, R.PH


Pharmacist
2480 Llewellyn Ave Ste 5800, Fort George G Meade, MD 20755
301-677-8637    

female pharmacist

Dr. Chaltu Nemomssa Wakijra, PHARMACIST


Pharmacist
2480 Llewellyn Ave, Fort George G Meade, MD 20755
301-677-8611     301-677-8456

female pharmacist

Dr. Doris Rita Voigt, PHARM D


Pharmacist
2480 Llewellyn Ave, Fort George G Meade, MD 20755
301-677-8637     301-677-8456



female pharmacist

Heather M Groeschen, PHARM.D.


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
2480 Llewellyn Ave, Suite 5800 - Pharmacy, Fort George G Meade, MD 20755
301-677-8611    

female pharmacist

Dr. Hyun J Lee, PHARM.D


Pharmacist
2480 Llewellyn Ave, Fort George G Meade, MD 20755
301-677-8611    

female pharmacist

Jewel Danielle Hilliard, PHARMD


Pharmacist
2480 Llewellyn Ave, Fort George G Meade, MD 20755
301-677-8875    

female pharmacist

Krista White


Pharmacist
2480 Llewellyn Ave, Fort George G Meade, MD 20755
301-677-8800    

female pharmacist

Nona Edmerlynn Capili


Pharmacist
2480 Llewellyn Ave, Fort George G Meade, MD 20755
301-677-8637    

female pharmacist

Sarah Elizabeth Lipphardt, PHARM.D., BCACP


Pharmacist
2480 Llewellyn Ave, Pharmacy Service, Fort George G Meade, MD 20755
301-677-8800    

female pharmacist

Stacy R B Hoffman, PHARMD


Pharmacist
2480 Llewellyn Ave, Fort George G Meade, MD 20755
301-677-8611    

male pharmacist

Mr. William Atkins, PHARMACIST


Pharmacist
2480 Llewellyn Ave, Fort George G Meade, MD 20755
301-677-8611    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.